Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Type 2 diabetes

Journal articles and book chapters

10-29-2018 | Type 2 diabetes | Review | Article

Addressing clinical inertia in type 2 diabetes mellitus: A review

Okemah J, Peng J, Quiñones M. Adv Ther 2018. doi: 10.1007/s12325-018-0819-5

10-26-2018 | PCSK9 inhibitors | Review | Article

Inhibiting PCSK9: Biology beyond LDL control

Stoekenbroek RM et al. Nat Rev Endocrinol 2018. doi: 10.1038/s41574-018-0110-5

10-21-2018 | Sitagliptin | Article

A randomized clinical trial to evaluate the single‐dose pharmacokinetics, pharmacodynamics and safety of sitagliptin in pediatric patients with type 2 diabetes

Fraser IP et al. Pediatr Diabetes 2018. doi: 10.1111/pedi.12790

10-16-2018 | Metabolic surgery | Article

Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity

Fisher DP et al. JAMA 2018; 320: 1570–1582. doi: 10.1001/jama.2018.14619

10-15-2018 | Statins | Review | Article

Beyond statins: Who and when to prescribe?

Ganda O. Curr Diab Rep 2018; 18: 126. doi: 10.1007/s11892-018-1087-0

10-11-2018 | Pathophysiology | Review | Article

The α-cell in diabetes mellitus

Gromada J, Chabosseau P, Rutter GA. Nat Rev Endocrinol 2018. doi: 10.1038/s41574-018-0097-y

10-08-2018 | Complications | Review | Article

Diabetes and HIV

Noubissi EC, Katte JC, Sobngwi E. Curr Diab Rep 2018; 18: 125. doi: 10.1007/s11892-018-1076-3

10-08-2018 | Dapagliflozin | Article

Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure

Soga F et al. Cardiovasc Diabetol 2018; 17: 132. doi: 10.1186/s12933-018-0775-z

10-06-2018 | Healthcare costs | Article

A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: A post hoc analysis of the Steno-2 study

Gæde J et al. Diabetologia 2018. doi: 10.1007/s00125-018-4739-3

10-05-2018 | Hyperglycemia | Article

Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

This consensus report addresses the approaches to management of glycemia in adults with type 2 diabetes, with the goal of reducing complications and maintaining quality of life in the context of comprehensive cardiovascular risk management and patient-centered care.

10-04-2018 | Mobile technology | Review | Article

App-based insulin calculators: Current and future state

Eiland L et al. Curr Diab Rep 2018; 18: 123. doi: 10.1007/s11892-018-1097-y

09-24-2018 | Atherosclerosis | Article

Prevention of atherothrombotic events in patients with diabetes mellitus: From antithrombotic therapies to new-generation glucose-lowering drugs

Patti G et al. Nat Rev Cardiol 2018. doi: 10.1038/s41569-018-0080-2

09-14-2018 | Insulin glargine/Lixisenatide | Article

Bedtime-to-morning glucose difference and iGlarLixi in type 2 diabetes: Post hoc analysis of LixiLan-L

Zisman A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0507-0

09-14-2018 | Psychosocial care | Article

Improved treatment engagement among patients with diabetes treated with insulin glargine 300 U/mL who participated in the COACH support program

Goldman JD et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0501-6

09-13-2018 | Pathophysiology | Review | Article

Altered gut microbiota in type 2 diabetes: Just a coincidence?

Sircana A et al. Curr Diab Rep 2018; 18: 98. doi: 10.1007/s11892-018-1057-6

09-12-2018 | SGLT2 inhibitors | Article

Comparative risk of genital infections associated with SGLT2 inhibitors: A real‐world retrospective cohort study

Dave CV et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13531

09-12-2018 | Retinopathy | Article

The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: A meta-analysis

Cai X et al. Endocrine 2018. doi: 10.1007/s12020-018-1697-y

09-10-2018 | Insulin glargine | Article

Association of patient profile with glycemic control and hypoglycemia with insulin glargine 300 U/mL in type 2 diabetes: A post hoc patient-level meta-analysis

Twigg SM et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0498-x

09-05-2018 | Anti-hypertensive medications | Article

Alirocumab safety in people with and without diabetes mellitus: Pooled data from 14 ODYSSEY trials

Leiter LA et al. Diabet Med 2018. doi: 10.1111/dme.13817

09-05-2018 | Diet | Review | Article

Nutrition and diabetes in South Asia

Gopalan HS, Misra A, Jayawardena R. Eur J Clin Nutr 2018; 72: 1267–1273. doi: 10.1038/s41430-018-0219-6

Next Previous
Image Credits